v3.26.3
Investments in and Advances to Joint Ventures
9 Months Ended
Sep. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Investments in and Advances to Joint Ventures
14.
Investments in and Advances to Joint Ventures

The Company participates in joint ventures to bid, negotiate and complete specific projects. The Company is required to consolidate these joint ventures if it holds the majority voting interest or if the Company meets the criteria under the consolidation model, as described below.

The Company performs an analysis to determine whether its variable interests give the Company a controlling financial interest in a Variable Interest Entity (“VIE”) for which the Company is the primary beneficiary and should, therefore, be consolidated. Such analysis requires the Company to assess whether it has the power to direct the activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE.

The Company analyzed all of its joint ventures and classified them into two groups: (1) joint ventures that must be consolidated because they are either not VIEs and the Company holds the majority voting interest, or because they are VIEs and the Company is the primary beneficiary; and (2) joint ventures that do not need to be consolidated because they are either not VIEs and the Company holds a minority voting interest, or because they are VIEs and the Company is not the primary beneficiary.

Many of the Company’s joint venture agreements provide for capital calls to fund operations, as necessary; however, such funding is infrequent and is not anticipated to be material.

Letters of credit outstanding described in “Note 10 – Debt and Credit Facilities” that relate to project joint ventures are $166.1 million and $184.4 million at September 30, 2026 and December 31, 2025, respectively.

In the table below, aggregated financial information relating to the Company’s joint ventures is provided because their nature, risk and reward characteristics are similar. None of the Company’s current joint ventures that meet the characteristics of a VIE are individually significant to the consolidated financial statements.

Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

 

 

 

September 30, 2026

 

 

December 31, 2025

 

Current assets

 

$

480,003

 

 

$

542,877

 

Noncurrent assets

 

 

6,305

 

 

 

7,961

 

Total assets

 

 

486,308

 

 

 

550,838

 

Current liabilities

 

 

269,649

 

 

 

301,891

 

Noncurrent liabilities

 

 

3,076

 

 

 

3,417

 

Total liabilities

 

 

272,725

 

 

 

305,308

 

Total joint venture equity

 

$

213,583

 

 

$

245,530

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Revenue

 

$

198,691

 

 

$

213,752

 

 

$

577,638

 

 

$

602,905

 

Costs

 

 

172,046

 

 

 

178,123

 

 

 

496,643

 

 

 

505,145

 

Net income

 

$

26,645

 

 

$

35,629

 

 

$

80,995

 

 

$

97,760

 

Net income attributable to noncontrolling interests

 

$

13,258

 

 

$

17,671

 

 

$

40,297

 

 

$

48,514

 

 

The assets of the consolidated joint ventures are restricted for use only by the particular joint venture and are not available for the Company’s general operations. The liabilities of the consolidated joint ventures are obligations of the respective joint ventures, and creditors of these joint ventures do not have recourse to the general credit of the Company.

Unconsolidated Joint Ventures

The Company accounts for its unconsolidated joint ventures using the equity method of accounting. Under this method, the Company recognizes its proportionate share of the net earnings of these joint ventures as “Equity in (losses) earnings of unconsolidated joint ventures” in the consolidated statements of income. The Company’s maximum exposure to loss as a result of its investments in unconsolidated joint ventures is typically limited to the aggregate of the carrying value of the investment and future funding commitments.

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

 

 

 

September 30, 2026

 

 

December 31, 2025

 

Current assets

 

$

1,373,495

 

 

$

1,549,367

 

Noncurrent assets

 

 

411,609

 

 

 

439,496

 

Total assets

 

 

1,785,104

 

 

 

1,988,863

 

Current liabilities

 

 

843,237

 

 

 

1,046,970

 

Noncurrent liabilities

 

 

458,554

 

 

 

469,833

 

Total liabilities

 

 

1,301,791

 

 

 

1,516,803

 

Total joint venture equity

 

$

483,313

 

 

$

472,060

 

Investments in and advances to unconsolidated joint ventures

 

$

174,764

 

 

$

148,640

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Revenue

 

$

599,294

 

 

$

608,305

 

 

$

1,331,238

 

 

$

1,558,656

 

Costs

 

 

551,887

 

 

 

563,832

 

 

 

1,318,855

 

 

 

1,476,009

 

Net income

 

$

47,407

 

 

$

44,473

 

 

$

12,383

 

 

$

82,647

 

Equity in earnings of unconsolidated joint ventures

 

$

7,242

 

 

$

8,266

 

 

$

(20,350

)

 

$

6,937

 

 

The Company had net contributions to its unconsolidated joint ventures of $14.3 million and $0.2 million for the three months ended September 30, 2026 and September 30, 2025, respectively and $50.5 million and $7.5 million for the nine months ended September 30, 2026 and September 30, 2025, respectively.

 

The following table presents certain financial statement impacts from changes in estimates on an unconsolidated joint venture in the Critical Infrastructure segment, driven by increases in costs to complete. In certain instances, revisions in estimates on unconsolidated joint ventures do not exceed the threshold in any particular quarter but exceed the threshold on a year-to-date basis (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Operating loss

 

$

-

 

 

$

-

 

 

$

(40,854

)

 

$

(14,478

)

Net loss

 

 

-

 

 

 

-

 

 

 

(35,053

)

 

 

(10,869

)

Diluted loss per share

 

$

-

 

 

$

-

 

 

$

(0.33

)

 

$

(0.10

)